Laure, Argie D.

HRN: 05-76-32  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2025
CEFUROXIME 1.5GM (VIAL)
05/05/2025
05/12/2025
IV
1.5grams
Q8, 1Hr PTOR
Cholelithiasis
Rejected 
05/04/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/05/2025
05/12/2025
IV
500mg
1hr PTOR
Cholelithiasis
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: